Meditech Laboratories v. LSCD4635 CA2/2

CourtCalifornia Court of Appeal
DecidedMarch 10, 2022
DocketB306218
StatusUnpublished

This text of Meditech Laboratories v. LSCD4635 CA2/2 (Meditech Laboratories v. LSCD4635 CA2/2) is published on Counsel Stack Legal Research, covering California Court of Appeal primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Meditech Laboratories v. LSCD4635 CA2/2, (Cal. Ct. App. 2022).

Opinion

Filed 3/10/22 Meditech Laboratories v. LSCD4635 CA2/2 NOT TO BE PUBLISHED IN THE OFFICIAL REPORTS California Rules of Court, rule 8.1115(a), prohibits courts and parties from citing or relying on opinions not certified for publication or ordered published, except as specified by rule 8.1115(b). This opinion has not been certified for publication or ordered published for purposes of rule 8.1115.

IN THE COURT OF APPEAL OF THE STATE OF CALIFORNIA

SECOND APPELLATE DISTRICT

DIVISION TWO

MEDITECH LABORATORIES, INC., B306218

Plaintiff and Respondent, (Los Angeles County Super. Ct. No. BC576721) v.

LSCD4635, INC.,

Defendant and Respondent;

BUSINESS SERVICES OF AMERICA, INC.,

Objector and Appellant.

APPEAL from a judgment of the Superior Court of Los Angeles County. Edward B. Moreton, Jr., Judge. Affirmed.

Shulman Bastian Friedman & Bui and Shane M. Biornstad for Objector and Appellant.

Dumas & Kim, James A. Dumas and Christian T. Kim for Defendant and Respondent. ______________________________ After defendant and respondent LSCD4635, Inc. (LSCD or the judgment creditor) obtained a judgment in its favor and against Meditech Laboratories, Inc. (Meditech), it moved to amend the judgment pursuant to Code of Civil Procedure section 1871 to add appellant Business Services of America, Inc. (BSA or the judgment debtor) as a judgment debtor. The trial court granted LSCD’s motion. In so doing, it overruled all of BSA’s evidentiary objections to LSCD’s evidence pursuant to California Rules of Court, rule 3.1354(c) (rule 3.1354). BSA appeals, arguing that the trial court committed prejudicial error in overruling its evidentiary objections. We agree with BSA that the trial court erred in relying upon rule 3.1354 when it overruled BSA’s objections to evidence. But, BSA has not demonstrated on appeal that this error was prejudicial. Accordingly, we affirm. FACTUAL AND PROCEDURAL BACKGROUND LSCD obtains a judgment against Meditech Meditech and LSCD entered into a services agreement and later brought claims against each other for breach of contract. They eventually arbitrated their claims, and on July 6, 2018, the arbitrator issued an interim award in favor of LSCD. The corrected final award was issued on October 1, 2018.2 On

1 All further statutory references are to the Code of Civil Procedure unless otherwise indicated. 2 Notably, the arbitrator found LSCD’s president, Stephen Cobos (Cobos), “clear, direct, consistent and knowledgeable about the events at issue.” But it found Meditech’s manager, Quoc Daniel Huan Ha (Ha), “evasive” and unclear; his evasive testimony “seriously eroded his credibility.”

2 January 29, 2019, the trial court confirmed the arbitrator’s award and entered judgment in favor of LSCD and against Meditech in the amount of $2,520,464.40. LSCD’s motion to amend the judgment On November 18, 2019, LSCD filed a motion to amend the judgment to add BSA as a judgment debtor. LSCD argued that BSA is an alter ego of Meditech under a single enterprise theory. In support, LSCD offered the following evidence: (1) a declaration from its president, Cobos; (2) a declaration from counsel with 37 attached exhibits; (3) an expert declaration; (4) a request for judicial notice of 30 exhibits; (5) excerpts from the prejudgment deposition of Meditech’s principal, Kim Tran Ha (Tran); (6) excerpts from the prejudgment deposition of the judgment debtor’s president and Tran’s husband, Ha; and (7) excerpts from the judgment debtor examination of Meditech, for which Ha testified. A. Cobos Declaration As is relevant to the issues in this appeal, Cobos declared that throughout his dealings with Meditech, his “only contact was with Ha.” Once this litigation commenced, he “encountered [Tran] at her deposition but she didn’t even attend the arbitration hearing. The only person who attended the arbitration on the Meditech side, aside from the Meditech attorney, was [Ha], who was there every day.” B. Tran’s Prejudgment Deposition Testimony In her prejudgment deposition, Tran testified that she was the owner/president/director of Meditech. When asked who helped her produce the requested documents for her deposition, she replied that Ha had helped her because “he’s the management company that helps me with most business that

3 dealt with Meditech,” and the management company is BSA. She explained that BSA manages Meditech by doing “[p]retty much everything from accounting, payroll, . . . [hiring], . . . [d]ay-to-day business, administration, [and] compliance.” Tran further testified that she thought Meditech had a lease for a building in Laguna Hills, but she was not sure. That building is the same building where BSA is located. Although she was the president of Meditech, Tran did not seem to know a lot about its business. For example, when asked about an individual on the “management team,” Tran did not know if she was employed by Meditech. While she had to approve payroll, she did not necessarily see the names of her employees. “Ha pretty much advised me on the profits and loss.” Later, when asked about depositing checks, she replied: “To be honest with you, I don’t know. BSA takes care of all this, so I don’t know what the logistics of how this whole thing works. You could ask [Ha] about that.” She also testified about an agreement between Meditech and BSA concerning duplicate checks. But, she did not know what “their” agreement was. When asked who the parties to that agreement were, she replied Ha and Cobos. According to Tran, even though Ha was not a Meditech employee, he could enter into an agreement on its behalf because he “advised” her, he was “the management team,” and he was “the one who brought this business on. So he’s the one who pretty much negotiated the deals and whatnot for me.” In other words, if LSCD had questions about the protocol concerning duplicate checks, it needed to ask Ha. Regarding discovery responses, she indicated that Ha had helped her prepare them.

4 C. Ha’s Prejudgment Deposition Testimony Ha testified that he was a director of BSA. As director, he was “the president who run[s] the day-to-day work of BSA. And BSA does a lot of different things, from human resources to leave of compliance, to marketing, et cetera, et cetera.” BSA manages Meditech. When asked to provide an estimate of how Meditech was allegedly damaged by LSCD, Ha stated that he did not know and that he doubted Tran would know either. But part of Meditech’s alleged damages included a loan it allegedly was forced to get because LSCD owed it money. According to Ha, White Star Investment Universal Limited (of which Ha had at some point been a director or manager) loaned Meditech $400,000 pursuant to an oral agreement negotiated by Ha on behalf of Meditech through BSA. D. Exhibits Attached to Counsel’s Declaration Attached to LSCD’s counsel’s declaration were a host of documents. As pertains to the issues in this appeal, one document was a copy of the lease between QK Ha Family Limited Partnership and Meditech. Ha executed the lease on behalf of the lessor, and Tran executed the lease on behalf of Meditech. Also attached was a copy of a promissory note issued by Meditech for the benefit of the QK Ha Family Limited Partnership after the arbitration award had been issued against it. E. Request for Judicial Notice One document attached to LSCD’s request for judicial notice is a UCC filing acknowledgement from the California Secretary of State dated August 15, 2018 (after the interim arbitration award was issued) identifying Meditech as the debtor and BSA as the secured party. Another document was a UCC

5 financing statement, also filed in August 2018, identifying Meditech as the debtor and White Star Investment Universal Limited as the secured party. BSA’s opposition BSA opposed the motion to amend the judgment.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Toho-Towa Co. v. Morgan Creek Productions, Inc.
217 Cal. App. 4th 1096 (California Court of Appeal, 2013)
Mesler v. Bragg Management Co.
702 P.2d 601 (California Supreme Court, 1985)
People v. Watson
299 P.2d 243 (California Supreme Court, 1956)
Dow Jones & Co. v. Avenel
151 Cal. App. 3d 144 (California Court of Appeal, 1984)
NEC Electronics Inc. v. Hurt
208 Cal. App. 3d 772 (California Court of Appeal, 1989)
People v. Smith
179 Cal. App. 4th 986 (California Court of Appeal, 2009)
Jazayeri v. Mao
174 Cal. App. 4th 301 (California Court of Appeal, 2009)
Fremont Indemnity Co. v. Fremont General Corp.
55 Cal. Rptr. 3d 621 (California Court of Appeal, 2007)
Gatton v. A.P. Green Services, Inc.
64 Cal. App. 4th 688 (California Court of Appeal, 1998)
Remington Investments, Inc. v. Hamedani
55 Cal. App. 4th 1033 (California Court of Appeal, 1997)
Serri v. Santa Clara University
226 Cal. App. 4th 830 (California Court of Appeal, 2014)
Wells Fargo Bank v. Weinberg CA4/2
227 Cal. App. 4th 1 (California Court of Appeal, 2014)
Highland Springs Conference & Training Center v. City of Banning
244 Cal. App. 4th 267 (California Court of Appeal, 2016)
Christ v. Schwartz
2 Cal. App. 5th 440 (California Court of Appeal, 2016)
L&B Real Estate v. Superior Court
67 Cal. App. 4th 1342 (California Court of Appeal, 1998)
Greenspan v. LADT LLC
191 Cal. App. 4th 486 (California Court of Appeal, 2010)
Misik v. D'Arco
197 Cal. App. 4th 1065 (California Court of Appeal, 2011)
EHM Prods., Inc. v. Starline Tours of Hollywood, Inc.
230 Cal. Rptr. 3d 862 (California Court of Appeals, 5th District, 2018)
Sweetwater Union High Sch. Dist. v. Gilbane Bldg. Co.
434 P.3d 1152 (California Supreme Court, 2019)

Cite This Page — Counsel Stack

Bluebook (online)
Meditech Laboratories v. LSCD4635 CA2/2, Counsel Stack Legal Research, https://law.counselstack.com/opinion/meditech-laboratories-v-lscd4635-ca22-calctapp-2022.